보유 특허 상세 정보를 불러오는 중입니다...
[특허 요약] The present invention relates to a mixed-charge nanoparticle for inducing selective death of cancer cells and a use thereof. The mixed-charge nanoparticle of the present invention is localized and crystallized specifically in cancer cell lysosomes through a pH-dependent aggregation behavior due to the balance between positively charged ligands and negatively charged ligands on the surface thereof and can induce lysosomal membrane permeabilization (LMP) and lysosomal cell death mediated thereby, like cationic amphiphilic drugs (CADs) Exhibiting a cancer cell-specific death effect, the nanoparticles of the present invention can surmount the limited medical use of conventional cationic nanoparticles due to the non-specific cytotoxicity thereof. Particularly, the nanoparticles of the present invention do not exhibit toxicity to the human body and normal cells, thus finding useful applications in medical and medicinal uses such as for prevention and treatment of solid cancer, blood cancer, and tumors.
| 특허 상태 | 미공개 |
| 출원인 | 기초과학연구원, 울산과학기술원 |
| 발명자 | Bartosz Grzybowski, Kristiana Kandere-Grybowska, Magdalena Borkowaska, Marta Siek, Diana Kolygina |
| 출원번호 | 202117800990 |
| 출원일 | 2021.02.22 |
| 등록번호 | 20230211011A |
| 등록일 | 2023.07.06 |
| 중요 키워드 |
The present invention relates to a mixed-charge nanoparticle for inducing selective death of cancer cells and a use thereof. The mixed-charge nanoparticle of the present invention is localized and crystallized specifically in cancer cell lysosomes through a pH-dependent aggregation behavior due to the balance between positively charged ligands and negatively charged ligands on the surface thereof and can induce lysosomal membrane permeabilization (LMP) and lysosomal cell death mediated thereby, like cationic amphiphilic drugs (CADs) Exhibiting a cancer cell-specific death effect, the nanoparticles of the present invention can surmount the limited medical use of conventional cationic nanoparticles due to the non-specific cytotoxicity thereof. Particularly, the nanoparticles of the present invention do not exhibit toxicity to the human body and normal cells, thus finding useful applications in medical and medicinal uses such as for prevention and treatment of solid cancer, blood cancer, and tumors.







| 출원번호 | 출원일 |
| 1020210023424 | 2021.02.22 |
| 종류코드 | |
| A | |
| 외부 링크 | |
연관 기술이전 로딩 중...
연관 연구자 로딩 중...
nanoparticlescellsmixedchargegroup |


























| 출원번호 | 출원일 |
| 2021002208 | 2021.02.22 |
| 종류코드 | |
| A1 | |
| 외부 링크 | |